F&S THERAPLATE LTD

Company number 15322715 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

F&S THERAPLATE LTD - Analysis Report

Company Number: 15322715

Analysis Date: 2025-07-29 16:05 UTC

  1. Risk Rating: HIGH
    The company shows significant solvency concerns with net liabilities of £29,597 as of the latest accounts. Current liabilities substantially exceed current assets, and long-term creditors further increase financial strain.

  2. Key Concerns:

  • Negative Net Assets and Shareholders' Funds: The company’s net liabilities suggest it is insolvent on a balance sheet basis, raising doubts about its ability to meet obligations.
  • High Long-Term Creditors (£123,527): The level of non-current liabilities is large relative to the asset base, indicating potential over-reliance on debt financing or delayed repayment schedules.
  • Limited Operating History and Small Scale: Incorporated only in December 2023, with micro-entity accounts and minimal share capital (£102), the company has limited operational track record to demonstrate sustainability or cash flow generation.
  1. Positive Indicators:
  • No Overdue Filings or Compliance Issues: Accounts and confirmation statements are up to date, showing management attention to regulatory compliance.
  • Directors Actively Involved and Shareholding Concentrated Among Directors: Two directors hold significant shareholding and voting control, which may support stronger governance and commitment.
  • Micro-entity Reporting and Small Employee Base: Operating as a micro-entity with only two employees may allow for lean cost structure and flexibility during early growth.
  1. Due Diligence Notes:
  • Investigate the nature and terms of the £123,527 long-term creditors to understand repayment obligations and any related party transactions.
  • Review the company’s cash flow forecasts and business plan to assess how it intends to resolve the negative equity and achieve operational stability.
  • Obtain detailed profit and loss data to evaluate revenue generation, margins, and expense management, which are not disclosed in the micro-entity accounts.
  • Confirm any contingent liabilities or off-balance-sheet commitments that may impact financial health.
  • Assess the background and financial capacity of directors/shareholders to support the company if additional funding is required.

Perspective: Investment Risk Assessor · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.